PL333056A1 - Composition intended to treat asthma, containing loratadin and a hyperaemia reducing drug - Google Patents

Composition intended to treat asthma, containing loratadin and a hyperaemia reducing drug

Info

Publication number
PL333056A1
PL333056A1 PL97333056A PL33305697A PL333056A1 PL 333056 A1 PL333056 A1 PL 333056A1 PL 97333056 A PL97333056 A PL 97333056A PL 33305697 A PL33305697 A PL 33305697A PL 333056 A1 PL333056 A1 PL 333056A1
Authority
PL
Poland
Prior art keywords
loratadin
hyperaemia
composition intended
treat asthma
reducing drug
Prior art date
Application number
PL97333056A
Inventor
Alan G Harris
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of PL333056A1 publication Critical patent/PL333056A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL97333056A 1996-10-31 1997-10-29 Composition intended to treat asthma, containing loratadin and a hyperaemia reducing drug PL333056A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US73966996A 1996-10-31 1996-10-31

Publications (1)

Publication Number Publication Date
PL333056A1 true PL333056A1 (en) 1999-11-08

Family

ID=24973307

Family Applications (1)

Application Number Title Priority Date Filing Date
PL97333056A PL333056A1 (en) 1996-10-31 1997-10-29 Composition intended to treat asthma, containing loratadin and a hyperaemia reducing drug

Country Status (21)

Country Link
EP (1) EP0941091A1 (en)
JP (1) JP2000505104A (en)
KR (1) KR20000052922A (en)
CN (1) CN1235545A (en)
AR (1) AR008908A1 (en)
AU (1) AU731756B2 (en)
BR (1) BR9712705A (en)
CA (1) CA2268546A1 (en)
CO (1) CO4910128A1 (en)
CZ (1) CZ150999A3 (en)
HU (1) HUP9904075A3 (en)
ID (1) ID23431A (en)
IL (1) IL129662A0 (en)
NO (1) NO992062D0 (en)
NZ (1) NZ335078A (en)
PE (1) PE11399A1 (en)
PL (1) PL333056A1 (en)
SK (1) SK54599A3 (en)
TR (1) TR199901003T2 (en)
WO (1) WO1998018470A1 (en)
ZA (1) ZA979731B (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2307790A1 (en) * 1997-10-29 1999-05-06 J-Med Pharmaceuticals, Inc. Antihistamine/decongestant regimens for treating rhinitis
US6132758A (en) * 1998-06-01 2000-10-17 Schering Corporation Stabilized antihistamine syrup
IT1303671B1 (en) * 1998-07-28 2001-02-23 Nicox Sa SALTS OF NITRIC ACID WITH ACTIVE DRUGS IN THE TREATMENT OF DISEASES OF THE RESPIRATORY SYSTEM
AR022378A1 (en) * 1998-09-10 2002-09-04 Schering Corp METHODS AND COMPOSITIONS TO TREAT SINUSITIS, MEDIUM OTITIS AND OTHER RELATED DISORDERS USING ANTIHISTAMINS
US6521254B2 (en) 1998-12-07 2003-02-18 J-Med Pharmaceuticals, Inc. Single-dose antihistamine/decongestant formulations for treating rhinitis
ATE253354T1 (en) * 1999-02-23 2003-11-15 Yuhan Corp CAPSULES WITH COMPOSITIONS CONTAINING LORATADINE AND PSEUDOEPHEDRINE
KR100505899B1 (en) * 1999-02-23 2005-08-01 주식회사유한양행 Pharmaceutical capsule compositions containing loratadine and pseudoephedrine
WO2000057880A1 (en) * 1999-03-29 2000-10-05 Schering Corporation Methods and compositions for treating allergic and related disorders using fluorinated descarboethoxyloratadine
AU2277101A (en) * 1999-12-20 2001-07-03 Schering Corporation Stable extended release oral dosage composition
SK287105B6 (en) * 1999-12-20 2009-12-07 Schering Corporation Bilayer sustained release oral dosage composition
JP5592042B2 (en) * 2000-04-14 2014-09-17 ジェイ−メド ファーマシューティカルズ，インコーポレーティッド Single dose antihistamine / decongestant formulation for the treatment of rhinitis
AU2001264806A1 (en) * 2000-05-25 2001-12-03 Schering Corporation Stable liquid and solid formulations
MXPA03011705A (en) * 2001-06-20 2004-03-19 Schering Corp Antihistamines for the treatment of nasal congestion and nasal obstruction.
AU2005333081B2 (en) * 2005-06-17 2010-06-24 Aft Pharmaceuticals Limited Novel pharmaceutical composition and its use in a method for treatment of patients with upper respiratory mucosal congestion
EP2366381A1 (en) * 2006-06-01 2011-09-21 MSD Consumer Care, Inc. Phenylephrine pharmaceutical formulations and compositions for colonic absorption
NZ573174A (en) * 2006-06-01 2012-01-12 Msd Consumer Care Inc Sustained release pharmaceutical dosage form containing phenylephrine
KR101540191B1 (en) * 2014-02-24 2015-07-28 성균관대학교산학협력단 Composition comprising Loratadine for anti-inflammation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1110397A (en) * 1964-10-02 1968-04-18 Mead Johnson & Co Ephedrine composition
US4990535A (en) * 1989-05-03 1991-02-05 Schering Corporation Pharmaceutical composition comprising loratadine, ibuprofen and pseudoephedrine
US5407686A (en) * 1991-11-27 1995-04-18 Sidmak Laboratories, Inc. Sustained release composition for oral administration of active ingredient
US5314697A (en) * 1992-10-23 1994-05-24 Schering Corporation Stable extended release oral dosage composition comprising loratadine and pseudoephedrine
US5595997A (en) * 1994-12-30 1997-01-21 Sepracor Inc. Methods and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine

Also Published As

Publication number Publication date
ZA979731B (en) 1998-04-29
HUP9904075A3 (en) 2002-02-28
EP0941091A1 (en) 1999-09-15
CO4910128A1 (en) 2000-04-24
CZ150999A3 (en) 1999-10-13
KR20000052922A (en) 2000-08-25
BR9712705A (en) 1999-10-26
WO1998018470A1 (en) 1998-05-07
HUP9904075A2 (en) 2000-05-28
JP2000505104A (en) 2000-04-25
PE11399A1 (en) 1999-02-09
CA2268546A1 (en) 1998-05-07
AR008908A1 (en) 2000-02-23
NZ335078A (en) 2000-10-27
AU731756B2 (en) 2001-04-05
ID23431A (en) 2000-04-20
TR199901003T2 (en) 1999-07-21
NO992062L (en) 1999-04-29
SK54599A3 (en) 2000-08-14
CN1235545A (en) 1999-11-17
AU4995397A (en) 1998-05-22
IL129662A0 (en) 2000-02-29
NO992062D0 (en) 1999-04-29

Similar Documents

Publication Publication Date Title
CZ161599A3 (en) N-substituted 2-cynopyrrolidines, process of their preparation and their utilization as medicaments
PL333056A1 (en) Composition intended to treat asthma, containing loratadin and a hyperaemia reducing drug
ZA959321B (en) Process for purifying and isolating 2'-deoxy-2',2'-difluo-ronucleosides
GB9419536D0 (en) Medicaments
ZA953256B (en) Skin treatment composition
PL335555A1 (en) Novel compounds - substituted benzamides and therapeutic agent
EP0803255A4 (en) Medicinal composition
HK1040980A1 (en) Biphenylsulfonylcyanamides,process for their preparation, and their use as medicament
GB9405021D0 (en) Skin treatment composition
HU9500910D0 (en) Pyrazoline-derivatives and their use as plant desease-controlling agent
PL338123A1 (en) 6-pyrrolydin-2-ylpyridines, their production and application in therapy
AU3982695A (en) Oxazolyl- and thiazolylimidazo-benzo- and thienodiazepines and their use as medicaments
GB9418530D0 (en) Medicaments
ZA952120B (en) Skin treatment composition
GB9411052D0 (en) Medicaments
GB2291807B (en) Improvements in or relating to breathing devices
GB9416365D0 (en) Medicaments
GB9727276D0 (en) Improvements in medicaments for asthma treatment
GB9825972D0 (en) Improvements in medicaments for asthma treatment
EP0790829A4 (en) Medicaments
SI0991650T1 (en) Novel n-benzenesulphonyl-l-proline compounds, preparation method and use in therapy
GB9418269D0 (en) Improvements to inhalation devices
GB9707589D0 (en) Improvements in and relating to treatment
GB9406278D0 (en) Therapeutic agent
ZW1194A1 (en) Therapeutic agent